Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of colon and/or rectum
0.020 Biomarker disease BEFREE Together, TCR avidity enhancement may be leveraged by prime-boost immunization to improve GUCY2C-targeted colorectal cancer immunotherapeutic efficacy and patient outcomes without concomitant autoimmune toxicity. 28341670 2017
Malignant neoplasm of colon and/or rectum
0.020 Biomarker disease BEFREE This study identifies a novel genetic and clinical association between TCR-gamma and early-onset colorectal cancer. 11833498 2002